SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C218 - Cutting Edge Neuro-oncology Understanding Current Trends

Event Time: Thursday April 27, 2017 3:30 pm to 5:30 pm
Topic(s): Neuro-oncology
Director(s): Maciej Mrugala MD
Description: This program will aim to teach general neurologist and neuro-oncologist about most recent developments in the field of neuro-oncology. The first talk will cover new experimental therapies showing promise such as polio virus and immunotherapies using checkpoint inhibitors, among others. Patients are frequently asking about these therapies, and critical overview of the data for the practicing clinician will be provided. The second talk will address molecular diagnostics in primary brain tumors. This is an area of active research and many of the molecular markers recently discovered have clinical utility. Practical information about ordering different molecular panels and how to interpret them will be provided. In the third talk we will cover novel surgical techniques being already used or in stages of advanced development, in therapy for primary and metastatic brain tumors. We will emphasize information important for clinicians when advising patients about pros and cons of each therapeutic approach.
Completion Message: Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
3:30 PM - 3:35 PM Introduction Maciej Mrugala MD 
3:35 PM - 4:00 PM Evolving New Therapies in Neuro-oncology—What a Neurologist Should Know Maciej Mrugala MD 
4:00 PM - 4:45 PM Understanding Molecular Testing in Brain Tumors—How Clinically Useful Is It? Seema Nagpal MD 
4:45 PM - 5:30 PM Deciphering Technical Novelties in Surgical Therapy for Brain Tumors—What Is Coming and How to Advise the Patients? Bernard Bendok MD 

Disclosures

Speaker Disclosure
Bernard Bendok, MD Dr. Bendok has nothing to disclose.

Maciej M. Mrugala, MD Dr. Mrugala has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure, Abbvie.

Seema Nagpal, MD Dr. Nagpal has nothing to disclose.

Register Now

Related Courses

Sunday April 22, 2018

9:15 AM-12:00 PM
PL2 Presidential Plenary Session

Wednesday April 25, 2018

1:00 PM-3:00 PM
C148 Neurologic Consultations in Cancer Patients I Amy Pruitt MD
3:30 PM-5:30 PM
C163 Neurologic Consultations in Cancer Patients II Patrick Wen MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C177 Neuro-oncology in 2018: Navigating Current Trends Maciej Mrugala MD
1:00 PM-3:00 PM
C189 Neuro-oncologic Predicaments in the Hospital Setting Na Tosha Gatson MD, PhD
3:30 PM-5:30 PM
N6 Neuroscience in the Clinic: Neurologic Complications of Cancer Immunotherapy: A New Frontier in Neuro-Inflammation Antonio Omuro MD,
Andreas Hottinger MD

MEMBER LOG IN

Forgot Password?